Sirolimus Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 1 mg, 2 mg, 3 mg, 5 mg tablets
Reference Brands: Rapamune(US)
Category: Immune Disorder
Sirolimus inhibits mTOR, blocking T-cell activation and proliferation. It reduces organ rejection in transplant patients and treats certain autoimmune diseases. Benefits include effective immunosuppression, decreased rejection risk, and improved graft survival. Its selectivity for immune cells supports long-term disease control with manageable side effects.
Product Description: Sirolimus tablets, marketed as Rapamune, are approved in the US by the FDA and in the EU via EMA for preventing organ rejection and treating certain autoimmune conditions. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety, manufacturing data, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and manufacturing information, while the EMA ensures compliance with regional standards. For guidance on dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Ensuring adherence to regional regulations is essential for the safe, effective, and timely approval of sirolimus tablets worldwide, supporting optimal patient outcomes in transplantation and autoimmune therapy.
Sirolimus Tablet — third party manufacturing & bulk supply
Sirolimus Tablet is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Sirolimus Tablet is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Sirolimus Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Sirolimus Tablet →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Etrasimod Arginine
Strength:
2 mg, 4 mg, 6 mg
Form: Tablets
Reference Brands: Velsipity (USA)
View Details
Fostamatinib Disodium
Strength:
100 mg, 150 mg
Form: Tablets
Reference Brands: Tavalisse (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
